CLINICAL OTOLARYNGOLOGY is a prestigious peer-reviewed journal published by Wiley that focuses on advancing research in the field of otorhinolaryngology, including topics such as laryngeal surgery, sinus diseases, and head and neck oncology. With an ISSN of 1749-4478 and an E-ISSN of 1749-4486, this journal has established itself as a vital resource for healthcare professionals, researchers, and students interested in ear, nose, and throat (ENT) medicine. The journal is recognized for its rigorous standards, exemplified by its Q2 ranking in both the Medicine (Miscellaneous) and Otorhinolaryngology categories, as per the 2023 Scopus ranking, placing it within the 71st percentile among global journals in its field. Operating from its UK base in Hoboken, NJ, CLINICAL OTOLARYNGOLOGY also contributes to the scientific community's understanding of this specialized area of medicine, with a publication timeline spanning from 2005 to 2024. While it does not offer an open-access model, the journal's quality and impact make it a crucial platform for disseminating high-caliber research that informs clinical practices and fosters innovation in otolaryngology.

AURIS NASUS LARYNX, published by Elsevier Science Ltd, is a leading peer-reviewed journal specializing in the fields of otorhinolaryngology, surgery, and general medicine. Since its inception in 1974, this esteemed journal has been committed to disseminating high-quality research and innovative findings pertinent to the diagnosis, treatment, and management of ear, nose, and throat diseases. With an impressive 2023 impact factor reflected in its Q2 quartile rankings in both Medicine (miscellaneous) and Otorhinolaryngology, as well as its strong position in Surgery, AURIS NASUS LARYNX is regarded highly among researchers and practitioners. The journal is accessible through a subscription model, ensuring that essential knowledge remains within reach for both clinical and academic pursuits. The continuous evolution of its content promises to stay at the forefront of medical advancements, making it an invaluable resource for scholars, clinicians, and students striving for excellence in the medical field.

ORAL ONCOLOGY is a leading peer-reviewed journal published by Elsevier, dedicated to advancing the field of oncology with a specific focus on oral diseases and cancers. Since its inception in 1996, this esteemed journal has provided a platform for high-quality research that addresses critical issues in oral surgery, cancer research, and related disciplines. With impressive rankings in Q1 in Oncology and Q1 in Oral Surgery, and recognized as Rank #1 in Dentistry and Oral Surgery by Scopus, ORAL ONCOLOGY consistently publishes impactful articles that contribute significantly to our understanding of oral cancers. The journal is committed to sharing pioneering findings that enhance clinical practices and improve patient outcomes. As a non-open access journal, it provides readers with exclusive access to cutting-edge research, ensuring that professionals, researchers, and students are at the forefront of developments in the field. Situated in the United Kingdom, ORAL ONCOLOGY serves as an indispensable resource for those dedicated to advancing oral health and oncology research through rigorous scientific inquiry and collaboration.

BREAST is a leading peer-reviewed journal dedicated to advancing knowledge and practice in the fields of cancer research, oncology, and surgery, published by Churchill Livingstone. With an impressive impact factor and a prestigious Q1 ranking in multiple categories including Cancer Research, Medicine, and Surgery, the journal consistently delivers high-quality content that informs and inspires researchers, clinicians, and educators. Since its transition to Open Access in 2020, BREAST has significantly expanded its reach, providing immediate and unrestricted access to pivotal studies and findings in breast health and disease management. With a history dating back to 1992 and converging to 2024, the journal serves as an essential resource for the latest developments and innovative approaches in the clinical and biomedical aspects of breast care. Scholars and professionals alike can explore a wealth of research aimed at improving patient outcomes and fostering scientific dialogue in this vital area of healthcare.

ORL-Journal for Oto-Rhino-Laryngology Head and Neck Surgery is a prestigious peer-reviewed journal, published by KARGER, dedicated to advancing the field of otorhinolaryngology. With a rich history dating back to 1938, this journal addresses crucial developments in the diagnosis and treatment of disorders affecting the ear, nose, throat, and related structures of the head and neck. As per the 2023 Scopus rankings, it holds a commendable position of Q3 in the otorhinolaryngology category, showcasing its relevance and contribution to medical research. Currently indexed with an ISSN of 0301-1569 and an E-ISSN of 1423-0275, the journal fosters an academic environment for researchers, practitioners, and students to share their findings, case studies, and reviews. Although it operates on a traditional subscription model, its significant impact on the field makes it an essential resource for enhancing knowledge and practice in head and neck surgery. By encouraging rigorous research, ORL remains at the forefront of otorhinolaryngology, addressing the ever-evolving challenges and innovations in this dynamic medical specialty.

Laryngoscope Investigative Otolaryngology is a prominent open access journal published by Wiley, dedicated to advancing research and knowledge within the field of otolaryngology and surgical practices. Since its inception in 2016, this journal has undergone a transformative phase and has quickly established itself in the academic community, achieving Q2 quartile rankings in both Otorhinolaryngology and Surgery for the year 2023. With an ISSN of 2378-8038, it serves as a vital repository of innovative research, insights, and reviews, catering primarily to researchers, medical professionals, and students. The journal emphasizes accessibility, allowing wide dissemination of pivotal findings essential for fostering collaboration and enhancing clinical practices. Through its rigorous peer-review process and commitment to quality, Laryngoscope Investigative Otolaryngology seeks to contribute significantly to the ongoing dialogue and improvements within the health care landscape.

HEAD AND NECK: JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, published by Wiley, is a leading academic journal dedicated to advancing the field of otorhinolaryngology. With an impressive impact factor and ranked #5 out of 123 in the field according to Scopus, this journal serves as a premier platform for researchers, clinicians, and students alike to share and gain insights into cutting-edge developments related to head and neck sciences. With publication spanning from 1989 to 2024, it enjoys a Q1 ranking in the otorhinolaryngology category, reflecting its high quality and significant contribution to the scientific community. The journal is crucial for those aiming to stay at the forefront of research and clinical practices in this highly specialized area. This combination of rigorous peer review and a focus on both practical and experimental studies make HEAD AND NECK an essential resource for anyone involved in the healthcare and research sectors pertaining to the head and neck.

Head & Face Medicine, published by BMC, serves as a vital open-access platform for advancing research and clinical practices in the fields of Dentistry, Otorhinolaryngology, and Neurology. Since its inception in 2005, this journal has nurtured contributions that span a diverse range of topics, making significant strides in understanding complex head and facial conditions. With an impressive categorization in the 2023 Journal Rankings, where it is recognized in Q1 for both Dentistry and Otorhinolaryngology, as well as Q2 for Neurology, it holds a prestigious position in the academic community, fostering innovative ideas and collaborations. The journal's commitment to free access ensures widespread availability of groundbreaking research, promoting knowledge dissemination among researchers, healthcare professionals, and students alike. Located in the United Kingdom and continuously prioritizing rigorous peer review, Head & Face Medicine is essential for anyone seeking to stay at the forefront of medical advancements concerning head and facial health.

Welcome to the Australian Journal of Otolaryngology, a premier resource in the field of Otorhinolaryngology, published by AME Publishing Company. Established in 2018, this journal continues to be a vital platform for disseminating groundbreaking research and advancements in ear, nose, and throat medicine. With its commitment to open access, the journal strives to ensure that high-quality research is widely available to practitioners, researchers, and students alike. Positioned in the Q3 category for Otorhinolaryngology as of 2023, the journal is ranked #94 out of 123 in Scopus, indicating its increasing recognition in the academic community. The editorial board comprises distinguished experts dedicated to enhancing the understanding of otolaryngological disorders and treatments. We invite you to explore the latest findings and contribute to the growth of this dynamic field through your submissions.

South Asian Journal of Cancer, published by GEORG THIEME VERLAG KG, is a pivotal platform for research in the fields of oncology and cancer research. Established in 2012 and operating under an Open Access model, this journal aims to disseminate high-quality, peer-reviewed articles that address crucial developments in cancer treatment, prevention, and research, particularly within the South Asian context. Despite its young history, the journal has been positioned within the Q4 quartile for both Cancer Research and Oncology, and while current Scopus rankings indicate it resides in the lower percentiles, its commitment to amplifying regional voices and research is invaluable. With its headquarters in Stuttgart, Germany, and a global readership, South Asian Journal of Cancer is dedicated to enhancing collaboration among researchers, healthcare professionals, and students, fostering a space for innovative ideas and advancements in cancer care as we progress through to 2024.